Prelude Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRLD and other ETFs, options, and stocks.

About PRLD

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. 

CEO
Krishna Vaddi
CEOKrishna Vaddi
Employees
79
Employees79
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2016
Founded2016
Employees
79
Employees79

PRLD Key Statistics

Market cap
311.85M
Market cap311.85M
Price-Earnings ratio
-3.50
Price-Earnings ratio-3.50
Dividend yield
Dividend yield
Average volume
615.72K
Average volume615.72K
High today
$5.13
High today$5.13
Low today
$4.65
Low today$4.65
Open price
$4.82
Open price$4.82
Volume
175.96K
Volume175.96K
52 Week high
$5.54
52 Week high$5.54
52 Week low
$0.73
52 Week low$0.73

Stock Snapshot

The current Prelude Therapeutics(PRLD) stock price is $4.95, with a market capitalization of 311.85M. The stock trades at a price-to-earnings (P/E) ratio of -3.50.

During the trading session on 2026-05-05, Prelude Therapeutics(PRLD) shares reached a daily high of $5.13 and a low of $4.65. At a current price of $4.95, the stock is +6.4% higher than the low and still -3.5% under the high.

Trading volume for Prelude Therapeutics(PRLD) stock has reached 175.96K, versus its average volume of 615.72K.

Over the past 52 weeks, Prelude Therapeutics(PRLD) stock has traded between a high of $5.54 and a low of $0.73.

Over the past 52 weeks, Prelude Therapeutics(PRLD) stock has traded between a high of $5.54 and a low of $0.73.

People also own

Based on the portfolios of people who own PRLD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.